Table 1.
Basic characteristics of the included studies.
| References | Age (T/C) | Sample (T/C) | Intervention/control measures (T/C) | Intervention cycle | Outcome indicator |
|---|---|---|---|---|---|
| Ko et al. (16) | 61.9 ± 8.4/61.2 ± 15.0 | 20/20 | ST/AT | 8 weeks | SBP; DBP |
| Nemoto et al. (17) | 62.3 ± 11.7/61.2 ± 13.3 | 27/26 | ST/C | 16 weeks | SBP; DBP |
| Lamina et al. (18) | 58.27 ± 6.24 | 140/105 | AT/C | 8 weeks | SBP; DBP |
| Ng et al. (19) | 50 | 30/30 | AT/C | 8 weeks | SBP; DBP |
| Cornelissen et al. (20) | 59 | 26/22 | AT/ST | 10 weeks | SBP; DBP |
| Tsai et al. (21) | 48.8 ± 6.3/49.3 ± 7.2 | 52/50 | AT/C | 10 weeks | SBP; DBP |
| He et al. (22) | 58 ± 2/57 ± 2/58 ± 2 | 20/22/20 | AT/ST/C | 12 weeks | SBP; DBP |
| Zaleski et al. (23) | 52.3 ± 10.8 | 12/12 | AT/C | 12 weeks | SBP; DBP |
| Wong and Figueroa (24) | 57 ± 1/56 ± 1 | 14/14 | ST/C | 8 weeks | SBP; DBP |
| Dobrosielski et al. (25) | 57 ± 6/56 ± 6 | 51/63 | AT/C | 6 months | SBP; DBP |
| Huiming and Qian (26) | 55.7 ± 6.6/56.3 ± 7.5 | 39/41 | AT/C | 24 weeks | SBP; DBP |
| Jin-tao (27) | 48.20 ± 7.0/49.62 ± 6.1 | 50/50 | AT/C | 3 months | SBP; DBP |
| Chen et al. (28) | 45.77 ± 6.6/45.92 ± 7.2 | 48/48 | AT/C | 3 months | SBP; DBP |
| Hua et al. (29) | 52.37 ± 10.45/51.90 ± 10.18 | 47/46 | AT/C | 6 months | SBP; DBP |
| Shengli (30) | 50.48 ± 6.3/50.29 ± 6.1 | 61/61 | AT/C | 6 months | SBP; DBP |
| Guirong et al. (31) | 50.5 ± 5.6 | 171/149/149 | AT/ST/C | 4 weeks | SBP; DBP |
| Siu et al. (32) | 61.0 ± 5.7/62.2 ± 6.6/62.6 ± 6.2 | 181/181/181 | AT/ST/C | 12 weeks | SBP; DBP |
| Dos Santos et al. (33) | 63.1 ± 2.3/64.2 ± 3.1/62.6 ± 2.5 | 20/20/20 | AT/ST/C | 16 weeks | SBP; DBP |
| Headley et al. (34) | 58.0 ± 8.0; 57.1 ± 9.0 | 25/21 | AT/C | 16 weeks | SBP; DBP |